Approval · Notice of Compliance 8681 · 2007
ADVICOR: Notice of Compliance 8681
Issued March 29, 2007
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 8681
- Date
- March 29, 2007
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New strengths: 750/20 mg and 1000/40 mg, new maximum daily dose: 2000/40 mg and other revisions to the product monograph
- Therapeutic class
- Lipid metabolism regulator
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ADVICOR | Not yet assigned | — |
| ADVICOR | 02293498 | — |
| ADVICOR | 02293501 | Cancelled Post Market |
Medicinal ingredients
- LOVASTATIN 20 MG per TAB
- NICOTINIC ACID 500 MG per TAB
- NICOTINIC ACID 750 MG per TAB
- NICOTINIC ACID 1,000 MG per TAB
- LOVASTATIN 40 MG per TAB